WuXi Biologics (Cayman) Inc. carries a market capitalization of 26.07B, placing it among publicly traded companies globally.
| Market Cap | 26.07B |
| Enterprise Value | N/A |
WuXi Biologics (Cayman) Inc.'s stock has gained approximately 36.97749% over the past 52 weeks. The 50-day moving average sits at 12.89, while the 200-day moving average is 10.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | 36.97749% |
| 50-Day Moving Average | 12.89 |
| 200-Day Moving Average | 10.08 |
| Average Volume (20 Days) | N/A |
WuXi Biologics (Cayman) Inc.'s most recent stock split took place on December 10, 2020 with a 1:3 split ratio.
| Last Split Date | 12/10/2020 |
| Split Ratio | 1:3 |
Already premium?